Cargando…

Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy

BACKGROUND: Early recurrence of oesophageal squamous cell carcinoma (SCC) is defined as recurrence after surgery within 1 year, and appears as local recurrence, distant recurrence, and lymph node positive and disseminated recurrence. Contrast-enhanced computed tomography (CECT) is recommended for di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Sun, Ou, Jing, Liu, Jun, Wu, Yu-ping, Wu, Chang-qiang, Chen, Tian-wu, Zhang, Xiao-ming, Li, Rui, Tang, Meng-jie, Yang, Li-qin, Tan, Bang-guo, Lu, Fu-lin, Hu, Jiani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157695/ https://www.ncbi.nlm.nih.gov/pubmed/34039403 http://dx.doi.org/10.1186/s40644-021-00407-5

Ejemplares similares

Contrast-enhanced CT radiomics features to predict recurrence of locally advanced oesophageal squamous cell cancer within 2 years after trimodal therapy: A case-control study
por: Tang, Sun, et al.
Publicado: (2021)

CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study
por: Ou, Jing, et al.
Publicado: (2019)

The Use of Trimodality Treatment in Patients With Locally Advanced Oesophageal Squamous Cell Carcinoma: An Experience From a Large Cancer Centre in Pakistan
por: Qamar, Muhammad Fawad Ul, et al.
Publicado: (2023)

Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer
por: Piazzese, Concetta, et al.
Publicado: (2019)

Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model
por: Kong, Jie, et al.
Publicado: (2021)

Assessing Microcirculation in Resectable Oesophageal Squamous Cell Carcinoma with Dynamic Contrast-enhanced MRI for Identifying Primary tumour and Lymphatic Metastasis
por: Chen, Yan-li, et al.
Publicado: (2019)

Trimodal therapy in squamous cell carcinoma of the esophagus
por: Matuschek, C, et al.
Publicado: (2011)

Prognostic factors associated with (18)FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
por: Feng, Wei-Hsiang, et al.
Publicado: (2022)

Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study
por: Ji, Gu-Wei, et al.
Publicado: (2019)

Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy
por: Nevala-Plagemann, Christopher, et al.
Publicado: (2018)

Clinical-radiomic analysis for non-invasive prediction of liver steatosis on non-contrast CT: A pilot study
por: Tang, Shengnan, et al.
Publicado: (2023)

Tumor Stage-Based Gross Tumor Volume of Resectable Esophageal Squamous Cell Carcinoma Measured on CT: Association With Early Recurrence After Esophagectomy
por: Wu, Yu-ping, et al.
Publicado: (2021)

Radiomics analysis of contrast-enhanced CT for staging liver fibrosis: an update for image biomarker
por: Wang, Jincheng, et al.
Publicado: (2022)

Contrast-Enhanced CT-Based Radiomics Analysis in Predicting Lymphovascular Invasion in Esophageal Squamous Cell Carcinoma
por: Li, Yang, et al.
Publicado: (2021)

Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review
por: Decazes, Pierre, et al.
Publicado: (2021)

Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial
por: Shimodaira, Yusuke, et al.
Publicado: (2018)

Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients
por: Wadhwa, Roopma, et al.
Publicado: (2017)

Corrigendum: Contrast-Enhanced CT-Based Radiomics Analysis in Predicting Lymphovascular Invasion in Esophageal Squamous Cell Carcinoma
por: Li, Yang, et al.
Publicado: (2021)

Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
por: Chen, Wen, et al.
Publicado: (2021)

Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study
por: Zhou, Rui-Qin, et al.
Publicado: (2023)

Contrast‐enhanced CT‐based radiomic analysis for determining the response to anti‐programmed death‐1 therapy in esophageal squamous cell carcinoma patients: A pilot study
por: Yang, Qinzhu, et al.
Publicado: (2023)

Characterization of positioning uncertainties in PET‐CT‐MR trimodality solutions for radiotherapy
por: Hinault, Pauline, et al.
Publicado: (2022)

Non-Contrasted CT Radiomics for SAH Prognosis Prediction
por: Shan, Dezhi, et al.
Publicado: (2023)

Diagnosis of Acute Aortic Syndromes on Non-Contrast CT Images with Radiomics-Based Machine Learning
por: Ma, Zhuangxuan, et al.
Publicado: (2023)

Role of FDG-PET/CT in prediction of pathological tumor response and survival after trimodality therapy for esophageal squamous cell carcinoma
por: Hamai, Yoichi, et al.
Publicado: (2015)

Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT
por: O’Shea, Robert J., et al.
Publicado: (2022)

Personalized trimodal prehabilitation for gastrectomy
por: Bausys, Augustinas, et al.
Publicado: (2020)

Radiomics analysis of contrast-enhanced T1W MRI: predicting the recurrence of acute pancreatitis
por: Tang, Lingling, et al.
Publicado: (2023)

Definitive re-irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance status
por: W. Kim, Daniel, et al.
Publicado: (2020)

Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma
por: Cen, Chunyuan, et al.
Publicado: (2023)

A radiomics nomogram based on contrast-enhanced CT for preoperative prediction of Lymphovascular invasion in esophageal squamous cell carcinoma
por: Wang, Yating, et al.
Publicado: (2023)

Role of Cell-Cell Junctions in Oesophageal Squamous Cell Carcinoma
por: Xu, Qian-Rui, et al.
Publicado: (2022)

Trimodal Therapy in Esophageal Squamous Cell Carcinoma: Role of Adjuvant Therapy Following Neoadjuvant Chemoradiation and Surgery
por: Li, Xiaokun, et al.
Publicado: (2022)

ASO Author Reflections: Predicting Early Recurrence After Trimodality Therapy for Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Comprehensive genomic analysis of Oesophageal Squamous Cell Carcinoma reveals clinical relevance
por: Du, Peina, et al.
Publicado: (2017)

Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection
por: Li, Nu, et al.
Publicado: (2022)

CT-Based Radiomics Signature for the Preoperative Discrimination Between Head and Neck Squamous Cell Carcinoma Grades
por: Wu, Wenli, et al.
Publicado: (2019)

Heterogeneity of T3 stage esophageal squamous cell carcinoma in different parts based on enhanced CT radiomics
por: Li, Xiao-feng, et al.
Publicado: (2020)

The role of vascular invasion and lymphatic invasion in predicting recurrent thoracic oesophageal squamous cell carcinoma
por: Ma, Yu, et al.
Publicado: (2022)

Radiomic analysis in contrast-enhanced CT: predict treatment response to chemoradiotherapy in esophageal carcinoma
por: Hou, Zhen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pesdvcaq7l6rfv9srdtkim7g5g